Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026986 (
myelodysplastic syndrome
)
14,926
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inv(11)(p15q23), found in
myelodysplastic syndromes
and acute myeloid leukemia, leads to expression of a fusion protein consisting of the N-terminal of
nucleoporin 98
(
NUP98
) and the majority of the lysine methyltransferase 2A (KMT2A). To explore the transforming potential of this fusion we established inducible iNUP98-KMT2A transgenic mice. After a median latency of 80 weeks, over 90% of these mice developed signs of disease, with anemia and reduced bone marrow cellularity, increased white blood cell numbers, extramedullary hematopoiesis, and multilineage dysplasia. Additionally, induction of
iNUP98-KMT2A
led to elevated lineage marker-negative Sca-1
+
c-Kit
+
cell numbers in the bone marrow, which outcompeted wildtype cells in repopulation assays. Six
iNUP98-KMT2A
mice developed transplantable acute myeloid leukemia with leukemic blasts infiltrating multiple organs. Notably, as reported for patients, iNUP98-KMT2A leukemic blasts did not express increased levels of the
HoxA-B-C
gene cluster, and in contrast to KMT2A-AF9 leukemic cells, the cells were resistant to pharmacological targeting of menin and BET family proteins by MI-2-2 or JQ1, respectively. Expression of
iNUP98-KMT2A
in mouse embryonic fibroblasts led to an accumulation of cells in G1 phase, and abrogated replicative senescence. In bone marrow-derived hematopoietic progenitors, iNUP98-KMT2A expression similarly resulted in increased cell numbers in the G1 phase of the cell cycle, with aberrant gene expression of
Sirt1
,
Tert
,
Rbl2
,
Twist1
,
Vim
, and
Prkcd
, mimicking that seen in mouse embryonic fibroblasts. In summary, we demonstrate that
iNUP98-KMT2A
has
in vivo
transforming activity and interferes with cell cycle progression rather than primarily blocking differentiation.
...
PMID:Transforming activities of the
NUP98-KMT2A
fusion gene associated with myelodysplasia and acute myeloid leukemia. 3155 71